1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/29080
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCochrane, Tara-
dc.contributor.authorCampbell, Belinda A-
dc.contributor.authorGangatharan, Shane A-
dc.contributor.authorLatimer, Maya-
dc.contributor.authorKhor, Richard-
dc.contributor.authorChristie, David R H-
dc.contributor.authorGilbertson, Michael-
dc.contributor.authorRatnasingam, Sumita-
dc.contributor.authorPalfreyman, Emma-
dc.contributor.authorLee, Hui-Peng-
dc.contributor.authorTrotman, Judith-
dc.contributor.authorHertzberg, Mark-
dc.contributor.authorDickinson, Michael-
dc.date2021-
dc.date.accessioned2022-03-23T05:22:45Z-
dc.date.available2022-03-23T05:22:45Z-
dc.date.issued2021-12-
dc.identifier.citationInternal medicine journal 2021; 51(12): 2119-2128en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/29080-
dc.description.abstractThe management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.en
dc.language.isoeng-
dc.subjectHLen
dc.subjectHodgkin lymphomaen
dc.subjectPET adapteden
dc.subjectchemotherapyen
dc.subjectradiotherapyen
dc.titleAssessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternal medicine journalen
dc.identifier.affiliationMonash Health, Melbourne, Victoria, Australia..en
dc.identifier.affiliationBond University, Gold Coast, Queensland, Australia..en
dc.identifier.affiliationGenesiscare, Gold Coast, Queensland, Australia..en
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationACT Pathology and Canberra Hospital, Canberra, Australian Capital Territory, Australia..en
dc.identifier.affiliationUniversity of Western Australia, Perth, Western Australia, Australia..en
dc.identifier.affiliationFiona Stanley Hospital, Perth, Western Australia, Australia..en
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia..en
dc.identifier.affiliationPeter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia..en
dc.identifier.affiliationUniversity of NSW, Sydney, New South Wales, Australia..en
dc.identifier.affiliationDepartment of Haematology, Prince of Wales Hospital, Sydney, New South Wales, Australia..en
dc.identifier.affiliationUniversity of Sydney, Sydney, New South Wales, Australia..en
dc.identifier.affiliationConcord Repatriation General Hospital, Sydney, New South Wales, Australia..en
dc.identifier.affiliationFlinders Medical Centre, Adelaide, South Australia, Australia..en
dc.identifier.affiliationRoyal Darwin Hospital, Darwin, Northern Territory, Australia..en
dc.identifier.affiliationAndrew Love Cancer Centre, University Hospital Geelong, Geelong, Victoria, Australia..en
dc.identifier.affiliationDepartment of Haematology and Oncology, Western Health, Melbourne, Victoria, Australia..en
dc.identifier.affiliationSchool of Clinical Sciences, Monash University, Melbourne, Victoria, Australia..en
dc.identifier.affiliationDepartment of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia..en
dc.identifier.affiliationDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia..en
dc.identifier.affiliationSchool of Medicine, Griffiths University, Gold Coast, Queensland, Australia..en
dc.identifier.affiliationDepartment of Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/34505342/en
dc.identifier.doi10.1111/imj.15503en
dc.type.contentTexten
dc.identifier.orcidhttps://orcid.org/0000-0002-2668-1399en
dc.identifier.orcidhttps://orcid.org/0000-0002-7316-8723en
dc.identifier.orcidhttps://orcid.org/0000-0001-8009-4593en
dc.identifier.orcidhttps://orcid.org/0000-0002-1492-5966en
dc.identifier.orcid0000-0002-7057-2747en
dc.identifier.pubmedid34505342-
local.name.researcherKhor, Richard
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

56
checked on Mar 10, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.